Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estetrol/Drospirenone vs Ethinyl Estradiol/Drospirenone in PCOS: Impact on Testosterone and Clinical Outcomes
TCTR20250319011Phase 4Completed
- Sponsor
- Faculty of Medicine, Khon Kaen University
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in polycystic ovary syndrome (PCOS) comparing Estetrol + Drospirenone with Ethinyl Estradiol + Drospirenone (2 arms). Primary endpoint: Change in testosterone level. Started Mar 2025; status: completed.
02
Drugs
estetrolethinyl estradioldrospirenone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on TCTR20250319011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250319011.